Seeking Alpha

BPAX
Biosante Pharmaceuticals, Inc.

5/27/2012, 7:29 PM ET
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
BPAX Market Currents more »
  • March 20 BioSante Pharmaceuticals (BPAX) announces positive results from studies of its Pill-Plus oral contraceptive. The company is line to receive royalty payments on sales of Pill-Plus if it's eventually introduced in the U.S. Shares +14.1% premarket. [On the Move, Healthcare]
BPAX Latest Transcript more »
Currently, there are no transcripts for BPAX.
BPAX Cramer more »
Currently, there are no Cramer articles on BPAX.
BPAX Instablog posts more »
  • 8 Possible Explanations For BioSante Pharma's 56% Pop
    Tue, May 22 bioduediligence Comment!
  • BioSante Pharma $BPAX 1q-2012 Updates
    Sat, May 12 bioduediligence Comment!
  • 3 Biotech Stocks Undervalued
    Fri, Feb 17 Jorge Aura Comment!
  • BPAX shareholders wonder if there is a Gel for stock dysfunction!
    Wed, Jan 18 BullRyder Comment!
  • Investor Update for BioSante Pharmaceuticals (NasdaqGM: BPAX); Jefferies Initiating at Buy: Positive Ahead of Phase III LibiGel Data
    Tue, Nov 15, 2011 Investorideas.com Comment!
Write a post on BPAX
BPAX StockTalks
BPAX vs. ETF Alternatives
Company Description

We are a specialty pharmaceutical company focused on developing products for female sexual health, menopause, contraception and male hypogonadism. Our primary products are gel formulations of testosterone and estradiol. We also are engaged in the development of our proprietary calcium... More

Sector: Healthcare
Industry: Biotechnology
Country: United States